Rein Therapeutics to present late-breaking poster at ERS 2026 congress
Rein Therapeutics said it will present a late-breaking poster at the European Respiratory Society (ERS) 2026 Congress.
AUSTIN, Texas, Sept.
04, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") NASDAQ:RNTX, a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that it will present a late-breaking poster at the European Resp…